PharmiWeb.com - Global Pharma News & Resources
04-Feb-2019

Progressive Supranuclear Palsy - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Progressive Supranuclear Palsy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Progressive Supranuclear Palsy development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Progressive Supranuclear Palsy
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Progressive Supranuclear Palsy
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Progressive Supranuclear Palsy
  • The report also covers the dormant and discontinued pipeline projects related to Progressive Supranuclear Palsy

Topics Covered

1. Report Introduction

2. Progressive Supranuclear Palsy Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Progressive Supranuclear Palsy

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Featured

  • AB Science
  • Biogen
  • AbbVie
  • TauRx
  • Sellas Life Sciences
  • Delta Crystallon
  • AlzProtect
  • Asceneuron SA
  • Alectos Therapeutics
  • Cortice Biosciences
  • Intellect Neurosciences
  • Prana Biotechnology

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bjcl9x/progressive?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190204005652/en/

Editor Details

Last Updated: 04-Feb-2019